Advanced search
Publication Cover
Future Virology Volume 18, 2023 - Issue 7
Submit an article Journal homepage
2,291
Views
0
CrossRef citations to date
0
Altmetric
Editorial

COVID-19 Post Vaccination Neuronal Adverse Events: Probable Mechanisms and Treatment Possibilities

Abdul Mannan Baig1 Scientific Lead – Researcher COVID-19 and Long-COVID, Karachi, PakistanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0626-216X
ORCID Icon,
Joachim Gerlach2 Research & Development, Health-Shield, Langenfeld, Germany
,
Prakash Salunke3 Research & Development, Vedicinals-9, Talawade, Pune, Maharashtra, India
,
Rachel Jessey4 Consultant, Nutritionist, Hampshire, UK
&
Robin Rose5 Terrain Health, Stamford, Connecticut, CT06877, USA
Pages 399-401 | Received 22 Feb 2023, Accepted 31 May 2023, Published online: 16 Jun 2023

References

  • Baig AM , KhaleeqA , AliU , SyedaH. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci.11(7), 995–998 (2020).
  • Lamprinou M , SachinidisA , StamoulaE , VavilisT , PapazisisG. COVID-19 vaccines adverse events: potential molecular mechanisms. Immunol. Res.6, 1–17 (2023).
  • Lu L , XiongW , MuJet al. The potential neurological effect of the COVID-19 vaccines: a review. Acta Neurol. Scand.144(1), 3–12 (2021).
  • Mastropaolo M , HasbaniMJ. Small fiber neuropathy triggered by COVID-19 vaccination: association with FGFR3 autoantibodies and improvement during intravenous immunoglobulin treatment. Case Rep. Neurol.15(1), 6–10 (2023).
  • Hosseini R , AskariN. A review of neurological side effects of COVID-19 vaccination. Eur. J. Med. Res.28(1), 102 (2023).
  • Nabizadeh F , NooriM , RahmaniS , HosseiniH. Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: a systematic review. J. Clin. Neurosci.111, 57–70 (2023).
  • Alqatari S , IsmailM , HasanMet al. Emergence of post COVID-19 vaccine autoimmune diseases: a single center study. Infect. Drug Resist.16, 1263–1278 (2023).
  • Frontera JA , TamborskaAA , DoheimMFet al. Neurological events reported after COVID-19 vaccines: an analysis of VAERS. Ann. Neurol.91(6), 756–719 (2022).
  • Rastogi A , BingelieneA , StrafellaAP , Tang-WaiDF , WuPE , MandellDM. Reversible neurological and brain MRI changes following COVID-19 vaccination: a case report. J. Neuroradiol.49(6), 428–430 (2022).
  • Oh J , ChoWH , BarcelonE , KimKH , HongJ , LeeSJ. SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death. Sci. Rep.12(1), 5496 (2022).
  • Baig AM , GreigNH , GerlachJet al. Underlying causes and treatment modalities for neurological deficits in COVID-19 and long-COVID. ACS Chem. Neurosci.13(20), 2934–2938 (2022).
  • Hammarström P , NyströmS. Viruses and amyloids – a vicious liaison. Prion17(1), 82–104 (2023).
  • Hsueh SC , ScerbaMT , TweedieDet al. Activity of a novel anti-inflammatory agent F-3,6'-dithiopomalidomide as a treatment for traumatic brain injury. Biomedicines10(10), 2449 (2022).
  • Lecca D , HsuehSC , LuoWet al. Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury. J. Biomed. Sci.30(1), 16 (2023).
  • Yonker LM , SwankZ , BartschYCet al. Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation147(11), 867–876 (2023).
  • Altman NL , BerningAA , MannSCet al. Vaccination-associated myocarditis and myocardial injury. Circ. Res.132(10), 1338–1357 (2023).
  • García-Grimshaw M , Ceballos-LiceagaSE , Hernández-VanegasLEet al. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clin. Immunol.229, 108786 (2021).
  • Bonzano L , DjuricO , MancusoPet al. Incidence and characteristics of adverse events after COVID-19 vaccination in a population-based programme. Vaccines (Basel)10(7), 1111 (2022).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.